Naperol Investments Ltd
Incorporated in 1954, National Peroxide Ltd is engaged in Investment and Leasing business[1]
- Market Cap ₹ 377 Cr.
- Current Price ₹ 656
- High / Low ₹ 1,212 / 490
- Stock P/E 35.3
- Book Value ₹ 1,609
- Dividend Yield 1.37 %
- ROCE 1.07 %
- ROE 1.03 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.41 times its book value
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 51.3%
Cons
- Tax rate seems low
- Company has a low return on equity of 0.71% over last 3 years.
- Working capital days have increased from -5.93 days to 226 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Investment Company
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 196 | 233 | 233 | 306 | 402 | 208 | 226 | 232 | 2 | 2 | 20 | 27 | |
| 174 | 197 | 163 | 161 | 175 | 166 | 170 | 209 | 2 | 3 | 8 | 16 | |
| Operating Profit | 22 | 36 | 70 | 145 | 226 | 42 | 56 | 23 | -0 | -1 | 12 | 11 |
| OPM % | 11% | 15% | 30% | 47% | 56% | 20% | 25% | 10% | -13% | -32% | 58% | 41% |
| 6 | 7 | -2 | 11 | 19 | 1 | -15 | 10 | 376 | 0 | 0 | 0 | |
| Interest | 5 | 5 | 2 | 1 | 1 | 3 | 13 | 9 | 0 | 0 | 0 | 0 |
| Depreciation | 7 | 9 | 9 | 9 | 9 | 11 | 18 | 17 | 0 | 0 | 0 | 0 |
| Profit before tax | 16 | 29 | 57 | 146 | 235 | 29 | 12 | 7 | 376 | -1 | 12 | 11 |
| Tax % | 62% | 37% | 34% | 35% | 35% | 40% | -76% | 32% | 0% | -41% | 10% | 4% |
| 6 | 18 | 38 | 95 | 153 | 17 | 21 | 5 | 375 | -0 | 11 | 11 | |
| EPS in Rs | 10.93 | 31.53 | 66.46 | 166.88 | 268.47 | 30.47 | 36.51 | 8.93 | 658.33 | -0.65 | 18.51 | 18.75 |
| Dividend Payout % | 46% | 32% | 52% | 39% | 24% | 41% | 35% | 56% | 0% | 0% | 49% | 105% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -35% |
| 3 Years: | 142% |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -21% |
| 3 Years: | 260% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -18% |
| 3 Years: | -13% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 203 | 214 | 368 | 503 | 609 | 481 | 583 | 532 | 552 | 1,049 | 1,158 | 911 |
| 73 | 30 | 11 | 0 | 80 | 161 | 125 | 94 | 0 | 0 | 0 | 0 | |
| 62 | 60 | 55 | 76 | 88 | 94 | 71 | 63 | 1 | 23 | 42 | 3 | |
| Total Liabilities | 344 | 310 | 440 | 585 | 783 | 742 | 785 | 694 | 559 | 1,078 | 1,205 | 920 |
| 187 | 180 | 178 | 170 | 166 | 372 | 342 | 338 | 0 | 0 | 0 | 0 | |
| CWIP | 4 | 3 | 2 | 6 | 75 | 0 | 3 | 4 | 0 | 0 | 0 | 0 |
| Investments | 10 | 7 | 170 | 253 | 192 | 177 | 268 | 282 | 547 | 1,065 | 1,190 | 895 |
| 143 | 120 | 90 | 156 | 350 | 193 | 172 | 71 | 12 | 13 | 16 | 24 | |
| Total Assets | 344 | 310 | 440 | 585 | 783 | 742 | 785 | 694 | 559 | 1,078 | 1,205 | 920 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 22 | 59 | 94 | 148 | 16 | 61 | 9 | 1 | 1 | -3 | -9 | |
| -75 | 30 | -31 | -56 | -175 | -38 | -7 | 34 | 1 | 0 | 11 | 8 | |
| 54 | -51 | -28 | -35 | 35 | 14 | -49 | -49 | -3 | -1 | -6 | -2 | |
| Net Cash Flow | 0 | -0 | -0 | 3 | 8 | -9 | 4 | -6 | -0 | 1 | 2 | -3 |
| Free Cash Flow | -15 | 21 | 53 | 84 | 69 | -83 | 40 | -8 | 1 | 1 | -3 | -9 |
| CFO/OP | 117% | 81% | 105% | 93% | 100% | 62% | 118% | 52% | -646% | -313% | -29% | -69% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 51 | 52 | 64 | 28 | 57 | 38 | 30 | 193 | 0 | 74 | 101 |
| Inventory Days | 76 | 65 | 66 | 65 | 134 | 98 | 87 | 87 | 0 | 0 | ||
| Days Payable | 120 | 83 | 115 | 90 | 101 | 75 | 102 | 41 | ||||
| Cash Conversion Cycle | 25 | 33 | 4 | 39 | 61 | 80 | 23 | 76 | 193 | 0 | 74 | 101 |
| Working Capital Days | 107 | 101 | 62 | 115 | 229 | 230 | 197 | 42 | -85 | -302 | 59 | 226 |
| ROCE % | 9% | 13% | 21% | 33% | 39% | 5% | 6% | 1% | -0% | -0% | 1% | 1% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Capacity Utilization - Hydrogen Peroxide % |
|
||||||||
| Installed Capacity - Hydrogen Peroxide (50% w/w) MTPA |
|||||||||
| Production Volume - Hydrogen Peroxide (50% w/w) MT |
|||||||||
| Power Consumption per Unit of Production KWH/MT |
|||||||||
| Sales Volume - Hydrogen Peroxide (50% w/w) MT |
|||||||||
| Domestic Market Share - Hydrogen Peroxide % |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 1 May
-
Announcement under Regulation 30 (LODR)-Change in Management
30 Apr - Manager of the Company has resigned from the Company effective May 31, 2026
- Corporate Action-Board approves Dividend 30 Apr
-
Appointment of Company Secretary and Compliance Officer
30 Apr - Board approved FY26 audited results, recommended Rs16.48 dividend, and appointed company secretary; manager resigns May 31, 2026.
-
Financial Results For Financial Year Ended March 31, 2026
30 Apr - Board approved FY26 audited results, recommended Rs16.48 final dividend, and appointed new Company Secretary.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Services Offered:[1]
a) Manufacturing, distribution and dealing
of peroxygen chemicals
b) Making long term investments and corporate lending directly and/or through its wholly owned subsidiary viz., the Transferor Company.